Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
Status:
Not yet recruiting
Trial end date:
2027-06-01
Target enrollment:
Participant gender:
Summary
This project aims to evaluate the efficacy and safety of the combination of glucocorticoids
with tocilizumab or tofacitinib, compared to the traditional combination of glucocorticoids
with cyclophosphamide in the treatment of vascular Behçet's syndrome.